Your session is about to expire
← Back to Search
Peanut SLIT-Tablet for Peanut Allergy
Study Summary
This trial is testing if it's safe to use a peanut allergy tablet.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have been diagnosed with or have a history of eosinophilic esophagitis.I am between 4 and 65 years old.I had severe reactions to peanut protein during a test.I am 4 years old or older and have needed asthma medication for the past 3 months.I am not increasing my dose of any allergy shots, except for peanut allergy treatments.I am 5 or older with lung function less than 70% of what's expected.I am between 12 and 65 years old.I have asthma with a control score of 19 or below.
- Group 1: Cohort 9
- Group 2: Cohort 3
- Group 3: Cohort 4
- Group 4: Cohort 5
- Group 5: Cohort 6
- Group 6: Cohort 7
- Group 7: Cohort 8
- Group 8: Cohort 10
- Group 9: Cohort 1
- Group 10: Cohort 2
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are recruitment efforts underway for this experiment?
"Affirmative. Clinicaltrials.gov records suggest that the treatment trial, uploaded on September 7th 2022 and last revised November 21st of this same year, is actively searching for 90 participants from 9 distinct sites."
Is there a widespread implementation of this research study across American healthcare institutions?
"Currently, 9 locations are enrolling participants for this clinical trial. These sites span from Louisville to Walnut creek and El Paso in addition to several other cities. Prospective volunteers should prioritize the nearest facility so as to reduce their transportation needs if they choose to participate."
Has the Peanut SLIT-tablet been accepted for use by the U.S Food and Drug Administration?
"As this trial is in Phase 1, there is only limited evidence of the Peanut SLIT-tablet's safety and efficacy. Thus, our team at Power assigned it a score of 1 on their scale."
Are individuals who exceed the age of 35 eligible to be part of this research study?
"Patients aged 4 to 65 are allowed entry into this trial, in addition to the 85 studies for minors and 156 trials catering to seniors."
Could I potentially qualify for this trial?
"This research initiative is looking to recruit 90 individuals aged 4-65 suffering from a documented, IgE-mediated peanut allergy. Participants must meet the following criteria: Inclusionary requirements for both parts of this trial (unless otherwise specified), Part 1: Males or females ages 18 through 65 on enrollment date, Part 2: Male or female between 4 and 65 years old upon matriculation into the study, Clinical history of an Immunoglobulin E mediated reaction towards food containing peanuts, Serum specific Immunoglobulin E ≥ 0.7 kUA/L at screening taken in a central laboratory setting, Skin prick test results with 5"
Is there a cap to the number of enrollees in this clinical research program?
"This medical study necessitates the participation of 90 individuals who satisfy the requirements. These recruits can be sourced from Family Allergy Asthma Research Institute in Louisville, Kentucky or Allergy & Asthma Clinical Research in Walnut Creek, California and other nearby locations."
Share this study with friends
Copy Link
Messenger